These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
516 related items for PubMed ID: 18025305
21. BH3 domains other than Bim and Bid can directly activate Bax/Bak. Du H, Wolf J, Schafer B, Moldoveanu T, Chipuk JE, Kuwana T. J Biol Chem; 2011 Jan 07; 286(1):491-501. PubMed ID: 21041309 [Abstract] [Full Text] [Related]
22. Bid chimeras indicate that most BH3-only proteins can directly activate Bak and Bax, and show no preference for Bak versus Bax. Hockings C, Anwari K, Ninnis RL, Brouwer J, O'Hely M, Evangelista M, Hinds MG, Czabotar PE, Lee EF, Fairlie WD, Dewson G, Kluck RM. Cell Death Dis; 2015 Apr 23; 6(4):e1735. PubMed ID: 25906158 [Abstract] [Full Text] [Related]
23. Predominant requirement of Bax for apoptosis in HCT116 cells is determined by Mcl-1's inhibitory effect on Bak. Wang C, Youle RJ. Oncogene; 2012 Jun 28; 31(26):3177-89. PubMed ID: 22056880 [Abstract] [Full Text] [Related]
26. Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation. Chen S, Dai Y, Harada H, Dent P, Grant S. Cancer Res; 2007 Jan 15; 67(2):782-91. PubMed ID: 17234790 [Abstract] [Full Text] [Related]
27. Contribution of BH3-domain and Transmembrane-domain to the Activity and Interaction of the Pore-forming Bcl-2 Proteins Bok, Bak, and Bax. Stehle D, Grimm M, Einsele-Scholz S, Ladwig F, Johänning J, Fischer G, Gillissen B, Schulze-Osthoff K, Essmann F. Sci Rep; 2018 Aug 20; 8(1):12434. PubMed ID: 30127460 [Abstract] [Full Text] [Related]
28. MCL-1ES induces MCL-1L-dependent BAX- and BAK-independent mitochondrial apoptosis. Kim JH, Bae J. PLoS One; 2013 Aug 20; 8(11):e79626. PubMed ID: 24260268 [Abstract] [Full Text] [Related]
29. Translocation of a Bak C-terminus mutant from cytosol to mitochondria to mediate cytochrome C release: implications for Bak and Bax apoptotic function. Ferrer PE, Frederick P, Gulbis JM, Dewson G, Kluck RM. PLoS One; 2012 Aug 20; 7(3):e31510. PubMed ID: 22442658 [Abstract] [Full Text] [Related]
30. The apoptosis promoting Bcl-2 homologues Bak and Nbk/Bik overcome drug resistance in Mdr-1-negative and Mdr-1-overexpressing breast cancer cell lines. Radetzki S, Köhne CH, von Haefen C, Gillissen B, Sturm I, Dörken B, Daniel PT. Oncogene; 2002 Jan 10; 21(2):227-38. PubMed ID: 11803466 [Abstract] [Full Text] [Related]
31. Myeloid cell leukemia-1 is an important apoptotic survival factor in triple-negative breast cancer. Goodwin CM, Rossanese OW, Olejniczak ET, Fesik SW. Cell Death Differ; 2015 Dec 10; 22(12):2098-106. PubMed ID: 26045046 [Abstract] [Full Text] [Related]
32. Crosstalk among Bcl-2 family members in B-CLL: seliciclib acts via the Mcl-1/Noxa axis and gradual exhaustion of Bcl-2 protection. Hallaert DY, Spijker R, Jak M, Derks IA, Alves NL, Wensveen FM, de Boer JP, de Jong D, Green SR, van Oers MH, Eldering E. Cell Death Differ; 2007 Nov 10; 14(11):1958-67. PubMed ID: 17703234 [Abstract] [Full Text] [Related]
36. The proteasome inhibitor MG132 potentiates TRAIL receptor agonist-induced apoptosis by stabilizing tBid and Bik in human head and neck squamous cell carcinoma cells. Sung ES, Park KJ, Choi HJ, Kim CH, Kim YS. Exp Cell Res; 2012 Aug 01; 318(13):1564-76. PubMed ID: 22513214 [Abstract] [Full Text] [Related]
37. Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Willis SN, Chen L, Dewson G, Wei A, Naik E, Fletcher JI, Adams JM, Huang DC. Genes Dev; 2005 Jun 01; 19(11):1294-305. PubMed ID: 15901672 [Abstract] [Full Text] [Related]